ArticleCancers2022

Baseline Splenic Volume Outweighs Immuno-Modulated Size Changes with Regard to Survival Outcome in Patients with Hepatocellular Carcinoma under Immunotherapy.

Lukas Müller et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.